Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Brand name: Alustal House Dust Mites Extract Initial Treatment Set TM
Active ingredients: american house dust mite extract + european house dust mite extract
What it is used for
Treatment of patients with Type 1 allergy (Gell and Coombs classification), particularly presenting as seasonal or perennial rhinitis, conjunctivitis, rhinoconjunctivitis, with or without associated asthma.
How to take it
This medicine is a pack that contains more than one part.
Part 1: Injection, suspension
Clear and colourless solution.
The way to take this medicine is: Subcutaneous. This medicine is injected, usually with a short needle or pen-like device, into the fat just beneath the skin.
Part 2: Injection, suspension
Clear and colourless solution.
The way to take this medicine is: Subcutaneous. This medicine is injected, usually with a short needle or pen-like device, into the fat just beneath the skin.
Part 3: Injection, suspension
Clear and colourless solution.
The way to take this medicine is: Subcutaneous. This medicine is injected, usually with a short needle or pen-like device, into the fat just beneath the skin.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Storage instructions
- Store at 2 to 8 degrees Celsius
- Do not Freeze
- Shelf lifetime is 18 Months.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Need more information?
These trusted information partners have more on this topic.